Cholic acid in combination with chenodeoxyholic acid for inborn errors for bile synthesis

Closed 24 Mar 2019

Opened 22 Feb 2019

Overview

NHS England has launched a 30 day consultation on a policy proposition for cholic acid in combination with chenodeoxyholic acid for inborn errors for bile synthesis.

This all ages policy is for the treatment of very rare genetic diseases relating to bile production, which affect the liver and the brain. The policy covers two drugs; cholic acid and chenodeoxycholic acid.

Related documents

Audiences

  • GPs
  • Nurses
  • Health visitors
  • Clinicians
  • Managers
  • Commissioners
  • Directors of public health
  • Pharmacists
  • Doctors
  • Midwives
  • Health care assistants
  • Healthcare scientists
  • Paramedics
  • Chiropodists/podiatrists
  • Dietitians
  • Occupation therapists
  • Orthotists
  • Orthopists
  • Prosthesists
  • Physiotherapists
  • Diagnostic radiographers
  • Therapeutic radiographers
  • Speech and language therapists
  • Childcare providers
  • Allied health professionals
  • Care-givers
  • Ophthalmic practitioners
  • Responsible officers
  • Clinical psychologists
  • Paediatric neuropsychologists
  • GP Practices
  • Clinical Nurse Specialist
  • Practice managers
  • Receptionists
  • Dental surgeons
  • Neonatal and maternity staff
  • Foundation trusts
  • Mental health trusts
  • Community healthcare trusts
  • Tribunal service
  • Clinical commissioning groups (CCGs)
  • Commissioning support units (CSUs)
  • Strategic clinical networks (SCNs)
  • GP Practices
  • Primary care
  • Care Quality Commission
  • Health Education England
  • Health Protection Agency
  • Local Government Association
  • Monitor
  • National Institute for Health and Care Excellence
  • Health and Wellbeing boards
  • Healthwatch (national and local)
  • Health and Social Care Information Centre
  • NHS Trust Development Authority
  • NHS England Partnership Organisations
  • National directors
  • Regional directors
  • Area Team directors
  • All NHS England Staff
  • All P&I staff
  • Policy leads
  • Voluntary groups
  • Community groups
  • Charities
  • Advocacy or support organisations
  • DH third sector strategic partners
  • Regulatory bodies
  • Academic/professional institutions
  • Employer representatives
  • Employee representatives
  • Trade unions
  • Deaneries
  • Higher education institutions
  • Royal Colleges
  • Service providers
  • All interested stakeholders
  • Pharmaceutical Industry
  • Local authorities
  • Social care providers
  • Patients
  • Carers
  • Service users
  • Retailers
  • Suppliers
  • Information providers
  • Information professionals
  • Informatics professionals

Interests

  • Specialised commissioning